Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with (177) Lu-PSMA-617. A single-center prospective observational study.

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., ...Daha Fazla

The Prostate, cilt.83, ss.792-800, 2023 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 83
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1002/pros.24518
  • Dergi Adı: The Prostate
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.792-800
  • Anahtar Kelimeler: Lu-177-PSMA-617, Ga-68-PSMA, FDG PET-CT, metastatic castration-resistant prostate carcinoma, prognostic factors, survival
  • Hacettepe Üniversitesi Adresli: Evet